Merck & Co Inc (NYSE:MRK)

82.51
Delayed Data
As of 6:30pm ET
 +0.48 / +0.59%
Today’s Change
66.10
Today|||52-Week Range
87.35
+7.98%
Year-to-Date
MRK Regular Dividend: MRK began trading ex-dividend on 09/13/19. A $0.55 dividend will be paid to shareholders of record as of 09/16/19.
Merck (MRK) Outpaces Stock Market Gains: What You Should Know
5:45pm / Zacks.com - Paid Partner Content
Roche's New Perjeta Combo Meets Goal in Breast Cancer Study
Sep 13 / Zacks.com - Paid Partner Content
Seattle Genetics' Enfortumab Vedotin BLA Gets Priority Review
10:44am / Zacks.com - Paid Partner Content
Renal Cell Carcinoma Space in Focus: Some Key Developments
Sep 13 / Zacks.com - Paid Partner Content
J&J Files sBLA for Tremfya With FDA for Psoriatic Arthritis
10:33am / Zacks.com - Paid Partner Content
Roche Reports Positive Data on Tecentriq & NMOSD Drug (Revised)
Sep 13 / Zacks.com - Paid Partner Content
Merck (MRK) is a Top Dividend Stock Right Now: Should You Buy?
Sep 16 / Zacks.com - Paid Partner Content
Momentum ETFs & Stocks in Focus as Trump Delays Tariff Hike
Sep 12 / Zacks.com - Paid Partner Content
Breast Cancer Drugs May Inflame Lungs Per FDA Safety Alert
Sep 16 / Zacks.com - Paid Partner Content
Horizon (HZNP) Up 36.7% YTD: Pipeline Development in Focus
Sep 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close82.03
Today’s open82.13
Day’s range82.13 - 83.50
Volume7,066,527
Average volume (3 months)9,514,136
Market cap$211.6B
Data as of 6:30pm ET, 09/17/2019

Growth & Valuation

Earnings growth (last year)+165.32%
Earnings growth (this year)+12.90%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)+6.17%
P/E ratio23.1
Price/Sales4.82
Price/Book8.02

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.33-0.90%
NVSNovartis+0.39+0.45%
AZNAstraZeneca+0.62+1.46%
SNYSanofi+0.70+1.61%
Data as of 6:30pm ET, 09/17/2019

Financials

Next reporting dateOctober 29, 2019
EPS forecast (this quarter)$1.23
Annual revenue (last year)$42.4B
Annual profit (last year)$6.2B
Net profit margin14.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts